Susan L Cohn

Susan L Cohn

UNVERIFIED PROFILE

Are you Susan L Cohn?   Register this Author

Register author
Susan L Cohn

Susan L Cohn

Publications by authors named "Susan L Cohn"

Are you Susan L Cohn?   Register this Author

100Publications

2312Reads

14Profile Views

The challenge of defining "ultra-high-risk" neuroblastoma.

Pediatr Blood Cancer 2019 Apr 26;66(4):e27556. Epub 2018 Nov 26.

Hospital for Sick Children and University of Toronto, Toronto, Canada.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/pbc.27556
Publisher Site
http://dx.doi.org/10.1002/pbc.27556DOI Listing
April 2019

Statistical Framework in Support of a Revised Children's Oncology Group Neuroblastoma Risk Classification System.

JCO Clin Cancer Inform 2018 12;2:1-15

Arlene Naranjo, University of Florida, Gainesville, FL; Meredith S. Irwin, Hospital for Sick Children, Toronto, ON, Canada; Michael D. Hogarty, University of Pennsylvania, Philadelphia, PA; Susan L. Cohn, The University of Chicago, Chicago, IL; Julie R. Park, University of Washington, Seattle, WA; and Wendy B. London, Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/CCI.17.00140DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421832PMC
December 2018

Immune Reconstitution Following Autologous Stem Cell Transplantation in Patients with High-Risk Neuroblastoma at the Time of Immunotherapy.

Biol Blood Marrow Transplant 2018 03 5;24(3):452-459. Epub 2017 Dec 5.

Department of Pediatrics, Section of Hematology/Oncology/Stem Cell Transplantation, University of Chicago, Chicago, Illinois. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.11.012DOI Listing
March 2018

Data Commons to Support Pediatric Cancer Research.

Am Soc Clin Oncol Educ Book 2017 ;37:746-752

From the University of Chicago, Chicago, IL; Children's Hospital of Philadelphia, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_175029DOI Listing
November 2017

Composite tumor with pheochromocytoma and immature neuroblastoma: report of two cases with cytogenetic analysis and discussion of current terminology.

Virchows Arch 2017 Oct 1;471(4):553-557. Epub 2017 Sep 1.

Department of Pathology, University of Chicago, 5841 S. Maryland Ave, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00428-017-2225-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614909PMC
October 2017

Evaluation of Genetic Predisposition for MYCN-Amplified Neuroblastoma.

J Natl Cancer Inst 2017 10;109(10)

Affiliations of authors: Section of Hematology/Oncology, Department of Pediatrics (EAH, MAA, ADS, SLV, SLC), Section of Genetic Medicine, Department of Medicine (BES), and Institute for Genomics and Systems Biology, Center for Data Intensive Science (BES), University of Chicago, Chicago, IL; Division of Oncology and Center for Childhood Cancer Research and Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA (ZV, MD, LM, JMM, SJD); Department of Pediatrics and Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA (JMM, SJD); Department of Pediatrics, Hofstra-Northwell School of Medicine and The Feinstein Institute for Medical Research, Manhasset, NY (KO).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djx093DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279278PMC
October 2017

Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting.

J Clin Oncol 2017 Aug 4;35(22):2580-2587. Epub 2017 May 4.

Julie R. Park, Seattle Children's Hospital and University of Washington School of Medicine, Seattle, WA; Rochelle Bagatell and John M. Maris, Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, PA; Susan L. Cohn, University of Chicago, Chicago, IL; Andrew D. Pearson, Institute of Cancer Research and Royal Marsden National Health Service (NHS) Foundation Trust, Sutton, Surrey; Susan Burchill, Leeds Institute of Cancer and Pathology, St James University Hospital, Leeds; Kieran McHugh and Penelope Brock, Great Ormond Street Hospital for Children, NHS Trust, London, United Kingdom; Judith G. Villablanca, Children's Hospital Los Angeles and University of Southern California Keck School of Medicine, Los Angeles; Katherine K. Matthay, University of California San Francisco School of Medicine, San Francisco, CA; Frank Berthold, Children's Hospital and University of Cologne, Köln, Germany; Ariane Boubaker, Institute of Radiology, Clinique de La Source, Lausanne, Switzerland; Jed G. Nuchtern, Texas Children's Hospital and Baylor College of Medicine, Houston, TX; Wendy B. London, Dana-Farber/Boston Children's Cancer and Blood Disorder Center, Harvard Medical School, Boston, MA; Nita L. Seibel and O. Wolf Lindwasser, National Cancer Institute, Bethesda, MD; Gudrun Schleiermacher, Institut Curie, Paris; Dominique Valteau-Couanet, Gustave Roussy, Villejuif, France; and Ruth Ladenstein, Children's Cancer Research Institute, St Anna Children's Hospital, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.72.0177DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676955PMC
August 2017

The Role of Nursing Professionals in the Management of Patients With High-Risk Neuroblastoma Receiving Dinutuximab Therapy.

J Pediatr Oncol Nurs 2017 May/Jun;34(3):160-172. Epub 2017 Jan 6.

5 Washington University School of Medicine and St. Louis Children's Hospital, St. Louis, MO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1043454216680595DOI Listing
May 2017

Rebound thymic hyperplasia following high dose chemotherapy and stem cell transplant in three neuroblastoma patients.

Pediatr Blood Cancer 2017 03 24;64(3). Epub 2016 Sep 24.

Department of Pediatrics, University of Washington, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.26226DOI Listing
March 2017

Emerging and investigational therapies for neuroblastoma.

Expert Opin Orphan Drugs 2017 17;5(4):355-368. Epub 2017 Mar 17.

Department of Pediatrics, University of Chicago, Chicago, Illinois, 60637, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/21678707.2017.1304212DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649635PMC
March 2017

Neuroblastoma survivors are at increased risk for second malignancies: A report from the International Neuroblastoma Risk Group Project.

Eur J Cancer 2017 02 26;72:177-185. Epub 2016 Dec 26.

Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pediatrics Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Abramson Family Cancer Research Institute, Philadelphia, PA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2016.11.022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5258837PMC
February 2017

Identification of different ALK mutations in a pair of neuroblastoma cell lines established at diagnosis and relapse.

Oncotarget 2016 Dec;7(52):87301-87311

Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, NE1 7RU, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.13541DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349989PMC
December 2016

Genetic discoveries and treatment advances in neuroblastoma.

Curr Opin Pediatr 2016 Feb;28(1):19-25

aDivision of Oncology, The Children's Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania bDepartment of Pediatrics, Comer Children's Hospital, University of Chicago, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOP.0000000000000296DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731097PMC
February 2016

Stem Cell Transplant-Associated Wernicke Encephalopathy in a Patient with High-Risk Neuroblastoma.

Pediatr Blood Cancer 2015 Dec 14;62(12):2232-4. Epub 2015 Jul 14.

Department of Pediatrics, Section of Hematology/Oncology/Stem Cell Transplantation, Comer Children's Hospital, University of Chicago, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.25650DOI Listing
December 2015

Surveillance of Childhood Cancer Survivors: A Lifelong Affair.

J Clin Oncol 2015 Nov 10;33(31):3531-2. Epub 2015 Aug 10.

University of Chicago, Chicago, IL

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.62.7703DOI Listing
November 2015

A Selfless Act.

Authors:
Susan L Cohn

J Clin Oncol 2015 Nov 10;33(32):3834-5. Epub 2015 Aug 10.

From the University of Chicago, Chicago, IL

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.62.5137DOI Listing
November 2015

Advances in Risk Classification and Treatment Strategies for Neuroblastoma.

J Clin Oncol 2015 Sep 24;33(27):3008-17. Epub 2015 Aug 24.

Navin R. Pinto, Mark A. Applebaum, Samuel L. Volchenboum, and Susan L. Cohn, Comer Children's Hospital, University of Chicago, Chicago, IL; Katherine K. Matthay, University of California San Francisco (UCSF) Benioff Children's Hospital, UCSF School of Medicine, San Francisco, CA; Wendy B. London, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA; Peter F. Ambros, Children's Cancer Research Institute, St Anna Kinderkrebsforschung, Vienna, Austria; Akira Nakagawara, Saga Medical Center Koseikan, Saga, Japan; Frank Berthold, Children's Hospital, University of Cologne, Koln, Germany; Gudrun Schleiermacher, Institut Curie, Paris; Dominique Valteau-Couanet, Gustave Roussy, Villejuif, France; Julie R. Park, Seattle Children's Hospital, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA; and Andrew D.J. Pearson, Institute of Cancer Research and Royal Marsden Hospital, Surrey, United Kingdom.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/33/27/3008.full.pdf
Web Search
http://200.40.135.66:90/toc/0873/2015/0873-20150920-27-07.pd
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.59.4648
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.59.4648DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567703PMC
September 2015

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs.

Authors:
Ayalew Tefferi Hagop Kantarjian S Vincent Rajkumar Lawrence H Baker Jan L Abkowitz John W Adamson Ranjana Hira Advani James Allison Karen H Antman Robert C Bast John M Bennett Edward J Benz Nancy Berliner Joseph Bertino Ravi Bhatia Smita Bhatia Deepa Bhojwani Charles D Blanke Clara D Bloomfield Linda Bosserman Hal E Broxmeyer John C Byrd Fernando Cabanillas George Peter Canellos Bruce A Chabner Asher Chanan-Khan Bruce Cheson Bayard Clarkson Susan L Cohn Gerardo Colon-Otero Jorge Cortes Steven Coutre Massimo Cristofanilli Walter J Curran George Q Daley Daniel J DeAngelo H Joachim Deeg Lawrence H Einhorn Harry P Erba Francisco J Esteva Elihu Estey Isaiah J Fidler James Foran Stephen Forman Emil Freireich Charles Fuchs James N George Morie A Gertz Sergio Giralt Harvey Golomb Peter Greenberg Jordan Gutterman Robert I Handin Samuel Hellman Paulo Marcelo Hoff Ronald Hoffman Waun Ki Hong Mary Horowitz Gabriel N Hortobagyi Clifford Hudis Jean Pierre Issa Bruce Evan Johnson Philip W Kantoff Kenneth Kaushansky David Khayat Fadlo R Khuri Thomas J Kipps Margaret Kripke Robert A Kyle Richard A Larson Theodore S Lawrence Ross Levine Michael P Link Scott M Lippman Sagar Lonial Gary H Lyman Maurie Markman John Mendelsohn Neal J Meropol Yoav Messinger Therese M Mulvey Susan O'Brien Roman Perez-Soler Raphael Pollock Josef Prchal Oliver Press Jerald Radich Kanti Rai Saul A Rosenberg Jacob M Rowe Hope Rugo Carolyn D Runowicz Brenda M Sandmaier Alan Saven Andrew I Schafer Charles Schiffer Mikkael A Sekeres Richard T Silver Lillian L Siu David P Steensma F Marc Stewart Wendy Stock Richard Stone Rainer Storb Louise C Strong Martin S Tallman Michael Thompson Naoto T Ueno Richard A Van Etten Julie M Vose Peter H Wiernik Eric P Winer Anas Younes Andrew D Zelenetz Charles A LeMaistre

Mayo Clin Proc 2015 Aug 23;90(8):996-1000. Epub 2015 Jul 23.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2015.06.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365030PMC
August 2015

Age-dependent prognostic effect by Mitosis-Karyorrhexis Index in neuroblastoma: a report from the Children's Oncology Group.

Pediatr Dev Pathol 2014 Nov-Dec;17(6):441-9. Epub 2014 Sep 10.

1 Department of Pathology & Laboratory Medicine, Children's Hospital Los Angeles, and University of Southern California Keck School of Medicine, 4650 Sunset Boulevard, MS #43, Los Angeles, CA 90027, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2350/14-06-1505-OA.1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340697PMC
March 2015

Second malignancies in patients with neuroblastoma: the effects of risk-based therapy.

Pediatr Blood Cancer 2015 Jan 23;62(1):128-33. Epub 2014 Sep 23.

Departments of Pediatrics, University of Chicago, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.25249DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237647PMC
January 2015

Significance of clinical and biologic features in Stage 3 neuroblastoma: a report from the International Neuroblastoma Risk Group project.

Pediatr Blood Cancer 2014 Nov 7;61(11):1932-9. Epub 2014 Jul 7.

Department of Hematology/Oncology, Children's National Medical Center, Washington, District of Columbia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.25134DOI Listing
November 2014

Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project.

J Clin Oncol 2014 Oct 25;32(28):3169-76. Epub 2014 Aug 25.

Kieuhoa T. Vo, Katherine K. Matthay, John Neuhaus, and Steven G. DuBois, Benioff Children's Hospital and University of California, San Francisco, San Francisco; Doug Miniati, Kaiser Permanente Medical Center, Roseville, CA; Wendy B. London, Children's Oncology Group Statistics and Data Center and Dana-Farber Children's Hospital Cancer Center, Boston, MA; Barbara Hero, Children's Hospital, University of Cologne, Köln, Germany; Peter F. Ambros, Children's Cancer Research Institute, St Anne Kinderkrebsforschung, Vienna, Austria; Akira Nakagawara, Chiba Cancer Center Research Institute and Chiba University, Chiba, Japan; Kate Wheeler, Oxford Children's Hospital, Oxford; Andrew D.J. Pearson, Institute of Cancer Research and Royal Marsden Hospital, Surrey, United Kingdom; Susan L. Cohn, The University of Chicago, Chicago, IL.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2014/08/25/JCO.2014.56
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.56.1621
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.56.1621DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171360PMC
October 2014

Secondary malignant neoplasms after high-dose chemotherapy and autologous stem cell rescue for high-risk neuroblastoma.

Pediatr Blood Cancer 2014 Aug 14;61(8):1350-6. Epub 2014 Mar 14.

Division of Hematology/Oncology/Stem Cell Transplant, Ann and Robert H. Lurie Children's Hospital of Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.25033DOI Listing
August 2014

Treatment of two cases with refractory, metastatic intermediate-risk neuroblastoma with isotretenoin alone or observation.

Pediatr Blood Cancer 2014 Jun 30;61(6):1104-6. Epub 2013 Nov 30.

Department of Pediatrics, Section of Pediatric Hematology/Oncology, The University of Chicago, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.24889DOI Listing
June 2014

TET1-mediated hydroxymethylation facilitates hypoxic gene induction in neuroblastoma.

Cell Rep 2014 Jun 15;7(5):1343-1352. Epub 2014 May 15.

Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL 60637, USA; Committee on Cancer Biology, University of Chicago, Chicago, IL 60637, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S22111247140034
Publisher Site
http://dx.doi.org/10.1016/j.celrep.2014.04.040DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516227PMC
June 2014

Neuroblastoma in older children, adolescents and young adults: a report from the International Neuroblastoma Risk Group project.

Pediatr Blood Cancer 2014 Apr 13;61(4):627-35. Epub 2013 Sep 13.

Division of Oncology, Children's Hospital of Philadelphia and Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.24777DOI Listing
April 2014

Metastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: A study from the International Neuroblastoma Risk Group Database.

J Clin Oncol 2014 Apr 24;32(12):1228-35. Epub 2014 Mar 24.

Daniel A. Morgenstern and Meredith S. Irwin, Hospital for Sick Children and University of Toronto; Derek Stephens, Hospital for Sick Children, Toronto, ON, Canada; Daniel A. Morgenstern, Great Ormond Street Hospital for Children National Health Service (NHS) Foundation Trust, London; Andrew D.J. Pearson, The Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom; Wendy B. London, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA; Samuel L. Volchenboum and Susan L. Cohn, University of Chicago, Chicago, IL; Barbara Hero, University Children's Hospital, Köln, Germany; Andrea Di Cataldo, University of Catania, Catania, Italy; Akira Nakagawara, Chiba University School of Medicine, Chiba, Japan; Hiroyuki Shimada, University of Southern California at Los Angeles, Los Angeles; Katherine K. Matthay, University of California at San Francisco, San Francisco, CA; and Peter F. Ambros, St. Anna Kinderkrebsforschung, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.53.6342DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876342PMC
April 2014

Development of an open-source, flexible framework for complex inter-institutional disparate data sharing and collaboration.

AMIA Jt Summits Transl Sci Proc 2013 18;2013:103. Epub 2013 Mar 18.

Department of Pediatrics, University of Chicago, Chicago, IL; ; Center for Research Informatics, University of Chicago, Chicago, IL;

View Article

Download full-text PDF

Source
December 2013

Children's Oncology Group's 2013 blueprint for research: neuroblastoma.

Pediatr Blood Cancer 2013 Jun 19;60(6):985-93. Epub 2012 Dec 19.

Seattle Children's Hospital, University of Washington School of Medicine and Fred Hutchinson Cancer Research Center, Seattle, WA 98106, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.24433DOI Listing
June 2013

Progression-free survival of two cases of high-risk neuroblastoma with refractory/relapsed disease following surgery alone.

Pediatr Blood Cancer 2013 Mar 5;60(3):512-4. Epub 2012 Nov 5.

Department of Pediatrics, University of Chicago, Chicago, Illinois 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.24385DOI Listing
March 2013

Two cases of localized neuroblastoma with multiple segmental chromosomal alterations and metastatic progression.

Pediatr Blood Cancer 2013 Feb 19;60(2):332-5. Epub 2012 Sep 19.

Department of Neuro-Oncology, Dana Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/pbc.24311
Publisher Site
http://dx.doi.org/10.1002/pbc.24311DOI Listing
February 2013

Trans-population analysis of genetic mechanisms of ethnic disparities in neuroblastoma survival.

J Natl Cancer Inst 2013 Feb 14;105(4):302-9. Epub 2012 Dec 14.

Section of Genetic Medicine, University of Chicago, 900 E 57th St, Rm 3220F, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djs503DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691940PMC
February 2013

Sorafenib inhibits neuroblastoma cell proliferation and signaling, blocks angiogenesis, and impairs tumor growth.

Pediatr Blood Cancer 2012 Oct 6;59(4):642-7. Epub 2011 Dec 6.

Departments of Pediatrics, University of Chicago, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.24004DOI Listing
October 2012

Locoregional MYCN-amplified neuroblastoma.

Pediatr Blood Cancer 2012 Oct 1;59(4):736-8. Epub 2012 Jan 1.

Department of Pediatrics, University of Chicago, Chicago, Illinois 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.24003DOI Listing
October 2012

Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastoma.

Target Oncol 2012 Sep 12;7(3):199-210. Epub 2012 Sep 12.

Department of Pediatrics, University of Chicago, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11523-012-0227-8DOI Listing
September 2012

New aspects of neuroblastoma treatment: ASPHO 2011 symposium review.

Pediatr Blood Cancer 2012 Jul 29;58(7):1099-105. Epub 2012 Feb 29.

Section of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.24116DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104176PMC
July 2012

Characteristics and outcome of patients with ganglioneuroblastoma, nodular subtype: a report from the INRG project.

Eur J Cancer 2012 May 1;48(8):1185-91. Epub 2011 Dec 1.

Department of Paediatrics, Division of Haematology and Oncology, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09598049110087
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2011.10.037DOI Listing
May 2012

Genetically InFormed therapies--a "GIFT" for children with cancer.

Clin Cancer Res 2012 May;18(10):2735-9

Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-1940DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3354647PMC
May 2012

Using germline genomics to individualize pediatric cancer treatments.

Clin Cancer Res 2012 May;18(10):2791-800

Department of Pediatrics and Medicine, and Committee on Clinical Pharmacology and Pharmacogenomics, University of Chicago, Chicago, Illinois 60637, USA.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-11-1938DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3354919PMC
May 2012

Opsoclonus-myoclonus and anti-Hu positive limbic encephalitis in a patient with neuroblastoma.

Pediatr Blood Cancer 2012 Mar 7;58(3):472-4. Epub 2011 Apr 7.

Department of Pediatrics, University of Chicago, 900 E. 57th Street, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.23131DOI Listing
March 2012

ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug efflux.

J Natl Cancer Inst 2011 Aug 28;103(16):1236-51. Epub 2011 Jul 28.

Experimental Therapeutics and Molecular Diagnostics Program, Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, University of New South Wales, P.O. Box 81, Randwick, NSW 2031, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djr256DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3156802PMC
August 2011

Pharmacokinetics of orally administered ABT-751 in children with neuroblastoma and other solid tumors.

Cancer Chemother Pharmacol 2010 Sep 1;66(4):737-43. Epub 2010 Jan 1.

Pediatric Oncology Branch, National Cancer Institute, 10 Center Drive, Bethesda, MD 20892-1101, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-009-1218-zDOI Listing
September 2010

Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors.

Mol Cancer 2010 Jun 4;9:138. Epub 2010 Jun 4.

Department of Pediatrics, University of Chicago, KCBD Rm. 5100, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1476-4598-9-138DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895596PMC
June 2010

Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines.

BMC Cancer 2010 Jun 14;10:286. Epub 2010 Jun 14.

Department of Pediatrics, University of Chicago, 900 Ease 57th Street, KCBD Rm, 5100 Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-10-286DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2897803PMC
June 2010

Modulation of matrix remodeling by SPARC in neoplastic progression.

Semin Cell Dev Biol 2010 Feb 1;21(1):55-65. Epub 2009 Dec 1.

Department of Pediatrics, Section of Hematology/Oncology, University of Chicago, Chicago, IL 60637, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semcdb.2009.11.018DOI Listing
February 2010

Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG.

Pediatr Blood Cancer 2009 Oct;53(4):563-9

Department of Pathology and Laboratory Medicine, Childrens Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, California 90027, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.22106DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2730988PMC
October 2009

Progress in defining and treating high-risk neuroblastoma: lessons from the bench and bedside.

J Clin Oncol 2009 Mar 26;27(7):1003-4. Epub 2009 Jan 26.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.20.2739DOI Listing
March 2009

Management of tumor lysis syndrome: need for evidence-based guidelines.

J Clin Oncol 2008 Dec 3;26(34):5657-8; author reply 5658-9. Epub 2008 Nov 3.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.19.6030DOI Listing
December 2008

Clinical significance of MYCN amplification and ploidy in favorable-stage neuroblastoma: a report from the Children's Oncology Group.

J Clin Oncol 2008 Feb;26(6):913-8

Children's Memorial Hospital, Department of Pediatrics, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.13.9493DOI Listing
February 2008

3 + 3 not equal to (Rolling) 6.

J Clin Oncol 2008 Jan;26(2):170-1

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.14.5052DOI Listing
January 2008